Principal Investigator: Sam Aparicio
Dr. Sam Aparicio
Sam Aparicio graduated in medical and natural sciences from Cambridge University (UK), clinical medicine from Oxford University (UK), and subsequently trained in internal medicine and pathology. After doctoral work with Sydney Brenner in Cambridge he held a Wellcome Trust Career Development Fellowship at the Wellcome/CRUK Developmental Biology Institute. From 2000-2005 he was a senior investigator in the Department of Oncology, Cambridge. He was a co-leader of the international consortium that sequenced the genome of the pufferfish Fugu Rubripes in 2002. He also co-founded (1999) the UK and Singapore based biotech company Paradigm Therapeutics (now Takeda Cambridge), where he was director of science until 2004.
Sam Aparicio is currently the Nan and Lorraine Robertson Chair of Breast Cancer Research, based at UBC/BC Cancer Agency, Vancouver, Canada; and a Canada Research Chair in Molecular Oncology. His work encompasses the fields of cancer genomics, mouse genetic models, high throughput screens, and translational breast cancer research.
saparicio [at] bccrc [dot] ca